Preventing congestive heart failure
- PMID: 9575327
Preventing congestive heart failure
Abstract
The morbidity, mortality and health care costs associated with congestive heart failure make prevention a more attractive public health strategy than treatment. Aggressive management of etiologic factors, including hypertension, coronary artery disease, valvular disease and excessive alcohol intake, can prevent the left ventricular remodeling and dysfunction that lead to heart failure. Early intervention with angiotensin converting enzyme inhibitors in patients with chronic left ventricular dysfunction can prevent, as well as treat, the syndrome. Several intervention strategies in patients with acute myocardial infarction can slow or prevent the left ventricular remodeling process that antedates congestive heart failure. The primary care physician must be alert to the need for aggressive intervention to reduce the burden of heart failure syndrome on the patient and on society.
Similar articles
-
[Prevention of heart failure].Arch Mal Coeur Vaiss. 1998 Nov;91(11):1333-41. Arch Mal Coeur Vaiss. 1998. PMID: 9864601 French.
-
Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.Diabetes Obes Metab. 2008 Jan;10(1):41-52. doi: 10.1111/j.1463-1326.2006.00688.x. Diabetes Obes Metab. 2008. PMID: 18095949
-
Mild heart failure: why the switch to ACE inhibitors?Geriatrics. 1993 Nov;48(11):47-8, 51-4. Geriatrics. 1993. PMID: 8224926 Review.
-
[Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].Ital Heart J. 2005 Nov;6 Suppl 7:24S-32S. Ital Heart J. 2005. PMID: 16485514 Review. Italian.
-
Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.Arch Intern Med. 2006 Apr 10;166(7):787-96. doi: 10.1001/archinte.166.7.787. Arch Intern Med. 2006. PMID: 16606817
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical